Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Weill Cornell Medical College, New York, New York, USA.
J Cataract Refract Surg. 2019 May;45(5):690-693. doi: 10.1016/j.jcrs.2018.12.030. Epub 2019 Mar 8.
To describe the successful treatment of epithelial ingrowth using combined surgical excision with intracameral adjuvant 5-fluorouracil (5-FU) followed by Descemet-stripping automated endothelial keratoplasty (DSAEK). A 71-year-old man presented with epithelial ingrowth after clear corneal phacoemulsification. He underwent surgical excision of the membrane together with pars plana vitrectomy, air fluid exchange, and intracameral 5-FU. This treatment resulted in corneal decompensation for which DSAEK was performed 6 months later. Despite interface haze, the postoperative corrected distance visual acuity returned to 20/40 three months after DSAEK. There was no clinical evidence of recurrence of the epithelial ingrowth 9 months after the surgical removal. Intracameral 5-FU can be used in conjunction with surgical excision and subsequent DSAEK to successfully treat epithelial ingrowth.
描述了使用联合手术切除联合房水内辅助 5-氟尿嘧啶(5-FU),随后进行 Descemet 撕囊自动内皮角膜移植术(DSAEK)治疗上皮内植入物成功的案例。一名 71 岁男性在接受透明角膜超声乳化术后出现上皮内植入物。他接受了膜的手术切除联合睫状体平坦部玻璃体切除术、空气液交换和房水内 5-FU。这种治疗导致角膜失代偿,6 个月后进行了 DSAEK。尽管存在界面混浊,但 DSAEK 术后 3 个月时,矫正后的远视力恢复至 20/40。在手术切除后 9 个月,没有上皮内植入物复发的临床证据。房水内 5-FU 可与手术切除联合使用,并随后进行 DSAEK 以成功治疗上皮内植入物。